Initial high-efficacy disease-modifying therapy in multiple sclerosisMathias Due Buron, Melinda Magyari, Peter Vestergaard Rasmussen et al.|Neurology|2020Cited by 160
Investigating the potential disease-modifying and neuroprotective efficacy of exercise therapy early in the disease course of multiple sclerosis: The Early Multiple Sclerosis Exercise Study (EMSES)Morten Riemenschneider, Ulrik Dalgas, Lars G. Hvid et al.|Multiple Sclerosis Journal|2022Cited by 48
Clinically stable disease is associated with a lower risk of both income loss and disability pension for patients with multiple sclerosisThor Ameri Chalmer, Melinda Magyari, Mathias Due Buron et al.|Journal of Neurology Neurosurgery & Psychiatry|2019Cited by 20
Patterns and predictors of multiple sclerosis phenotype transitionLuigi Pontieri, Melinda Magyari, Nupur Greene et al.|Brain Communications|2024Cited by 8
Discontinuation of dimethyl fumarate in multiple sclerosis - a nationwide studyMalte Roar, Tobias Sejbæk, Amalie Rhode Høgh Nielsen et al.|Multiple Sclerosis and Related Disorders|2023Cited by 3